About: Medicines regulation

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Medicines regulation Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Concept
rdfs:label	Medicines regulation
skos:inScheme	http://hub.abes.fr/referentiel/hwpjournalcoll
is Subject of	Educational interventions to reduce prescribing errors Adverse drug reactions in childhood: a review of prospective studies and safety alerts Supplement 902 Poliomyelitis and the Community Norwegian Scabies Clinical Uses of Currently Available Antibiotics To-day's Drugs Arterial clots and the pill. Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Medicine and the Media Measles in adults: a prospective study of 291 consecutive cases. Hospital accused of experiments on pregnant women Innovation in the pharmaceutical industry Unscientific assertions on treating asthma in general practice Skin necrosis induced by streptokinase Oral snuff “geared to addiction,” claim researchers Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials Data from transnational study of oral contraceptives have been misused Drugs must be tested for use in children Meta-analysis and the meta-epidemiology of clinical research Where now for AIDS vaccines? US effort to cut caesarean section rate may be harmful Medical abortion still not available in most countries Israeli health insurer curbs activities of drug representatives Incidence of venous thromboembolism in users of combined oral contraceptives Using information technology to reduce rates of medication errors in hospitals Why we need a broad perspective on meta-analysis FDA panel advises against omeprazole as over the counter drug Fortification of flour likely to halve neural tube defects, says CDC So many places for learning In brief Call for a new approach to the process of clinical trials and drug registration US approves new anti-leukaemia drug “Video pill” may supplement standard endoscopy Riluzole for motor neurone disease Bayer cuts price of ciprofloxacin after Bush threatens to buy generics Influx of fake drugs to Nigeria worries health experts Standards are needed for quality of life clinical trials Diabetic drug is often prescribed inappropriately, researchers say Treating seasonal allergic rhinitis Lack of new drugs is reaching crisis point, says review India admits to unapproved drug formulations in market Federal funding for comparative drug studies not in US budget HRT does not prevent chronic disease after menopause Bush signs law to protect US from bioterrorism Specialists challenge claim that fluoxetine plus talk therapy works best for depressed adolescents Counterfeits of impotence drug appear in the United Kingdom FDA approves implantable chip to access medical records Take forward the polypill idea, concludes expert committee The GMC: expediency before principle Findings from COX 2 studies are released Drug for heart failure increases mortality Triumph of the white male Legislation introduced to create a new drug safety office at the FDA Merck chief quits as further material on Vioxx emerges US study shows that folic acid fortification decreases neural tube defects NEJM stands by its criticism of Vioxx study Standards for infant formula milk FDA rejected contraception for political reasons WHO perspective on preventing avoidable harm from medicines Too close for comfort? CDC recommends expensive vaccine for all girls aged 11-12 US Institute of Medicine calls for major changes at FDA Regulator finds advertising of complementary product “misleading” Misuse of prescription drugs could soon exceed that of illicit narcotics, UN panel warns UK report recommends better planning for phase I drug trials Life saving treatment or giant experiment? Study indicates diabetes drug linked to cardiovascular death News Longer, better studies of coronary stents are needed, FDA tells industry Include cost of treatment Haemoglobin based blood substitutes raise risk of myocardial infarction and death Merck to pay $58m in settlement over rofecoxib advertising FDA begins active monitoring of drug safety FDA’s science board says the plastics chemical bisphenol A gives reason for concern Organisations reluctantly come out in support of top-up payments US Congress tells FDA to regulate tobacco Don’t try this at home? Should boys receive the human papillomavirus vaccine? Yes Neuraminidase inhibitors—the story behind the Cochrane review Has the European Clinical Trials Directive been a success? Missing published and unpublished data in guidelines Supplement 880 Proof of Harmlessness Mutants, hyperlipoproteinaemia, and coronary artery disease. Accident and emergency services. Design of departments. Self-reported health in people with Parkinson’s disease left untreated at diagnosis OBITUARY NOTICES Materia Non Medica NEWS AND NOTES Fulminant human T cell leukaemia lymphoma masquerading as acute viral infection of the nervous system. New Drugs: Practical clinical pharmacology: monitoring drug concentrations and clinical trials Bovine somatotropin and public health. Upjohn deliberately suppressed knowledge, says QC Bias in assignment to clinical trials Chickenpox vaccine gets approval in US Herbal stimulant causes US deaths

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata